While "GBF4 Antibody" is not documented, the following antibodies are notable for their specificity to similar or analogous targets:
Immunogenicity: Gb4Cer-VLCFAs (globotetraosylceramide with very-long-chain fatty acids) induce robust antibody responses in mice, including IgG3 and IgM subclasses. These antibodies recognize epitopes shared with Gb3Cer (a precursor glycosphingolipid) .
Pathological Roles: Gb4Cer promotes EGFR-mediated ERK signaling in cancer cells, enhancing proliferation. Depletion of Gb4Cer reduces ERK activation and cell growth .
Specificity: Targets DNA G-quadruplex structures, which are stable, guanine-rich DNA motifs implicated in genomic stability and cancer .
Applications:
ChIP-seq: Maps G-quadruplex formation in genomic regions.
Immunocytochemistry: Visualizes G-quadruplex localization in cells.
The term "GBF4" might refer to:
Glypican 4 (GPC4): A heparan sulfate proteoglycan involved in developmental signaling. Antibodies against GPC4 are used in cancer research (e.g., neuroblastoma, breast cancer) .
G-quadruplex-binding fragments: BG4 antibody or SG4 nanobodies target these structures, which are implicated in DNA replication and transcription .
Globosides: Gb4Cer antibodies study lipid signaling in autoimmune and cancer contexts .
Clarify Nomenclature: Verify whether "GBF4" refers to a novel target or a misidentified antibody.
Explore Structural Analogs: Investigate antibodies targeting G-quadruplexes (BG4), glycosphingolipids (Gb4Cer), or heparan sulfate proteoglycans (GPC4).
IgG4 Biology: Study IgG4 antibodies’ roles in immune tolerance or cancer immunity, leveraging their unique properties .